HUN Huntsman CORP
Chemicals & Allied Products · NYSE · SEC CIK 1307954 · Fiscal year ends 12/31
Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-4.7%
TTM net income YoY-111.5%
TTM EPS YoY-112.1%
Revenue 3-yr CAGR-8.5%
Net income 3-yr CAGR—
Margins
Gross margin12.9%
Operating margin-3.3%
Net margin-5.8%
FCF margin2.4%
EBITDA margin1.8%
Returns
ROE-11.8%
ROA-4.6%
ROIC (approx.)-3.3%
Asset turnover0.79x
Leverage & solvency
Liabilities / assets59.3%
Debt / equity0.77x
Current ratio1.27x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.93x
Accruals ratio-8.9%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q12026-03-31 | 2024Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 | 2024Q22024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.42B | $1.35B | $1.46B | $1.46B | $1.41B | $1.45B | $1.54B | $1.57B |
| Cost of revenue | $1.24B | $1.19B | $1.26B | $1.28B | $1.21B | $1.26B | $1.31B | $1.33B |
| Gross profit | $183.00M | $164.00M | $204.00M | $182.00M | $201.00M | $188.00M | $234.00M | $243.00M |
| R&D expense | $29.00M | $26.00M | $29.00M | $33.00M | $32.00M | $30.00M | $27.00M | $33.00M |
| SG&A expense | $163.00M | $181.00M | $163.00M | $160.00M | $166.00M | $166.00M | $153.00M | $176.00M |
| Operating income | -$16.00M | -$59.00M | $6.00M | -$120.00M | $42.00M | -$63.00M | $42.00M | $34.00M |
| Pretax income | -$29.00M | -$73.00M | -$7.00M | -$139.00M | $27.00M | -$81.00M | $34.00M | $44.00M |
| Income tax | $11.00M | $1.00M | $3.00M | $7.00M | $15.00M | $29.00M | $39.00M | $13.00M |
| Net income | -$53.00M | -$96.00M | -$25.00M | -$158.00M | -$5.00M | -$141.00M | -$33.00M | $22.00M |
| EBITDA | $57.00M | $14.00M | $79.00M | -$48.00M | $111.00M | $12.00M | $112.00M | $109.00M |
| EPS (basic) | -0.31 | — | -0.14 | -0.92 | -0.03 | — | -0.19 | 0.13 |
| EPS (diluted) | -0.31 | — | -0.14 | -0.92 | -0.03 | — | -0.19 | 0.13 |
| Dividends declared per share | 0.09 | 0.09 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Weighted avg. shares (diluted) | 173.00M | — | 172.60M | 172.60M | 172.40M | — | 172.10M | 172.80M |
| Balance sheet | ||||||||
| Cash & equivalents | $369.00M | $429.00M | $468.00M | $399.00M | $334.00M | $340.00M | $330.00M | $335.00M |
| Inventory | $885.00M | $818.00M | $836.00M | $896.00M | $1.03B | $917.00M | $1.00B | $923.00M |
| Current assets | $2.18B | $2.06B | $2.18B | $2.21B | $2.29B | $2.12B | $2.29B | $2.25B |
| PP&E, net | $2.44B | $2.49B | $2.48B | $2.49B | $2.49B | $2.49B | $2.58B | $2.55B |
| Goodwill | $628.00M | $630.00M | $628.00M | $631.00M | $637.00M | $633.00M | $643.00M | $640.00M |
| Intangibles | $298.00M | $308.00M | $317.00M | $328.00M | $334.00M | $344.00M | $358.00M | $366.00M |
| Total assets | $7.13B | $7.01B | $7.08B | $7.15B | $7.23B | $7.11B | $7.33B | $7.32B |
| Current liabilities | $1.72B | $1.59B | $1.60B | $1.54B | $1.54B | $1.56B | $1.56B | $1.73B |
| Short-term debt | $376.00M | $353.00M | $378.00M | $372.00M | $284.00M | $325.00M | $346.00M | $576.00M |
| Long-term debt | $1.68B | $1.66B | $1.63B | $1.66B | $1.67B | $1.51B | $1.51B | $1.34B |
| Total debt | $2.06B | $2.01B | $2.01B | $2.04B | $1.95B | $1.83B | $1.86B | $1.92B |
| Total liabilities | $4.23B | $4.06B | $4.08B | $4.09B | $4.06B | $3.95B | $3.99B | $3.98B |
| Shareholders' equity | $2.68B | $2.75B | $2.77B | $2.83B | $2.95B | $2.96B | $3.11B | $3.11B |
| Net debt | $1.69B | $1.58B | $1.54B | $1.64B | $1.62B | $1.50B | $1.53B | $1.58B |
| Shares outstanding | 173.35M | 172.62M | 172.60M | 172.60M | 172.60M | 172.14M | 172.14M | 172.13M |
| Cash flow statement | ||||||||
| Operating cash flow | -$53.00M | $76.00M | $196.00M | $91.00M | -$74.00M | $153.00M | $129.00M | $46.00M |
| Capital expenditure | $38.00M | $57.00M | $43.00M | $37.00M | $36.00M | $51.00M | $41.00M | $50.00M |
| Free cash flow | -$91.00M | $19.00M | $153.00M | $54.00M | -$110.00M | $102.00M | $88.00M | -$4.00M |
| Investing cash flow | -$37.00M | -$58.00M | -$42.00M | -$38.00M | $6.00M | -$39.00M | -$7.00M | -$50.00M |
| Financing cash flow | $30.00M | -$62.00M | -$83.00M | $9.00M | $60.00M | -$95.00M | -$129.00M | -$210.00M |
| Depreciation & amortization | $73.00M | $73.00M | $73.00M | $72.00M | $69.00M | $75.00M | $70.00M | $75.00M |
| Stock-based compensation | $9.00M | $8.00M | $7.00M | $7.00M | $9.00M | $7.00M | $7.00M | $7.00M |
| Dividends paid | $16.00M | $15.00M | $44.00M | $43.00M | $44.00M | $44.00M | $44.00M | $43.00M |
| Share buybacks | — | $0 | $0 | $0 | $0 | $3.00M | $0 | $0 |
Free plan shows the latest 8 periods; Pro shows all 68 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.